2018

1. Efficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC)

   Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286